Know Cancer

or
forgot password


Phase 4
18 Years
85 Years
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information


Patients having surgery for breast cancer receive a paravertebral blockade at C8-Th4 with
either Naropin 0.5% or saline. General anaesthesia is then provided with laryngeal mask
intubation, propofol infusion and fentanyl i.v. as needed. The effect on postoperative pain
([VAS] and fentanyl PCA doses taken) and postoperative nausea and vomiting is recorded.


Inclusion Criteria:



- Breast surgery

Exclusion Criteria:

- Infections

- Coagulation disorder

- Allergy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Outcome Measure:

Nausea and vomiting 2 hours postoperatively, and 1 and 2 days postoperatively

Outcome Time Frame:

2 days

Principal Investigator

Palle Carlsson, MD Dr Sci

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dept anesthesiology, Arhus University Hospital

Authority:

Denmark: National Board of Health

Study ID:

PVB1

NCT ID:

NCT00131170

Start Date:

September 2005

Completion Date:

September 2006

Related Keywords:

  • Breast Cancer
  • Breast Neoplasms

Name

Location